For the first time, Harvard University is entering the hazy world of cannabis research in a multi-million dollar partnership with a Canadian producer aimed at understanding the medicinal effects of marijuana.
on Tuesday that it had secured a research collaboration with Harvard Global Health Catalyst at the Ivy League research university鈥檚 medical school.
The Edmonton-based company is a founding partner of the new International Phytomedicines and Medical Cannabis Institute at the school.
鈥淚t was kind of a game-changing opportunity that would allow us to not only create a collaboration with a really credible institution, but of course have access to the minds that can help us really prove the science behind the plant,鈥� said Atlas CEO and President Sheldon Croome.
The initial partnership will last three years. Trials to study the effects of the drug, including whether they can play a role in chronic pain management and other neurological conditions, could begin as early as next year.
